Portal Hypertension Market Growth, Strategies, Forecast 2025 | Ono Pharmaceutical Co., Ltd.
At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike in liver cirrhosis, which may cause portal hypertension and other hepatic disorders.
Get Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=56
Portal hypertension results in increase of blood pressure within the portal venous system. It may cause veins in stomach, esophagus, umbilical area, or rectum to swell. In extreme cases, these swollen vein can rupture and bleed, thereby causing life-threatening complications.
Some of the noteworthy candidates under phase III of clinical trials are Udenafil (DA-8519), Sapropterin (tetrahydrobiopterin), and Octreolin (octreotide). When approved and launched, these drugs would have the potential to rake in substantial revenue in the market.
As far as diagnosis is concerned, Duplex Doppler ultrasonography has been seeing robust demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as angioplasty, computed tomography (CT) scanning, bleeding scan, and magnetic resonance imaging (MRI) are also considered aviable methods for precise diagnosis.
Noteworthy names operating in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., Dong-A Socio Holdings Co Ltd., Novartis AG, United Therapeutics Corporation, Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Chiasma, Inc., Govind Ballabh Pant Hospital, and Dr. Falk Pharma GmbH.
Global Portal Hypertension Market: Overview
Portal hypertension is a clinical condition in which blood pressure within the portal venous system increases. The condition may lead to the development of swollen veins within stomach, esophagus, umbilical area, or rectum. In severe cases, these swollen vein can rupture and bleed, thereby leading to potentially life-threatening complications. As per reports, liver cirrhosis is the most common cause of portal hypertension. Hence a rising incidence of liver cirrhosis is often related to the increasing demand for effective treatment for portal hypertension.
Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=56
In this report, TMR Research not only evaluates opportunities prevalent for the available treatment and diagnosis techniques for portal hypertension but also presents a detailed assessment of therapeutic pipeline. The potential market trajectory post approval of novel therapeutics is determined based on exhaustive information obtained from proven industrial sources. The report thus compiles data aimed at providing a comprehensive overview of the global portal hypertension market to the readers.
Global Portal Hypertension Market: Available Treatment Options
Duplex Doppler ultrasonography has been witnessing significantly high demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as a computed tomography (CT) scanning, bleeding scan, angioplasty, and magnetic resonance imaging (MRI) are also considered viable methods for precise diagnosis. As these constitute key segments in the global hypertension market, the report presents an in-depth analysis of the factors influencing the market’s trajectory across aforementioned segments.
The currently available treatment for portal hypertension includes medications comprising beta blockers such as Propranolol and Nadolol and endoscopic therapies such as sclerotherapy and banding. Vasoactive agents are also preferred in the treatment of portal hypertension due to its ability of reducing the in-variceal bleeding and ultimately helping to lower the blood pressure. In acute conditions vasoconstrictors such as octreotide and somastostatin are administered, which explains their high demand in the global portal hypertension market.
Global Portal Hypertension Market: Therapeutics and Pipeline Analysis
The global market for portal hypertension currently has a limited number of treatment options and there is absence of a specialized drugs approved to be administered for the treatment of portal hypertension. However, the generic drugs segment currently holds dominance in the market, the scope of treatment under which includes vasopressin and its analogues, beta blockers, and somatostatin and its analogues. This also demonstrates lucrative prospects for therapeutic research and development. As per TMR, the portal hypertension market is poised to exhibit exponential growth on account of the increasing incidence of liver cirrhosis, which may lead to portal hypertension and other hepatic disorders.
The pipeline analysis of the market consists of products currently under the phase III of clinical trials. Some of the most notable candidates are Sapropterin (tetrahydrobiopterin), Octreolin (octreotide), and Udenafil (DA-8519). Once approved, the launch of these drugs could generate high revenue for the market.
Global Portal Hypertension Market: Vendor Landscape
To study the competition prevailing in the global portal hypertension market, the report profiles a few of the companies operating therein. It conducts SWOT analysis to evaluate the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises could face over the course of the forecast period. Some of the prominent players in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., United Therapeutics Corporation, Chiasma, Inc., Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Dong-A Socio Holdings Co Ltd., Govind Ballabh Pant Hospital, Dr. Falk Pharma GmbH, and Novartis AG.
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Portal Hypertension Market Growth, Strategies, Forecast 2025 | Ono Pharmaceutical Co., Ltd. here
News-ID: 1803001 • Views: 81
More Releases from TMR Research
Conference Services Call Market 2028 | Zoom Video Communications, Polycom, Dialp …
Global Conference Call Services Market: Snapshot Conference calling has become the new normal in workplace communication in a globalized environment. This has formed a crucial role in making workplace more productive and agile. The global conference call services market is making rapid strides riding on the back of constant technological advancements made with respect to features and functionalities. A growing number of services offer hassle-free conference calling and promise to take
Trend Expected to Guide Swarm Intelligence Market During 2017 to 2025
Global Swarm Intelligence Market: Overview Swarm intelligence refers to the way that a number of artificial and natural systems composed of several individuals coordinate with the help of self-organization and decentralized control. Particularly, it focuses on the collective behaviors of these systems resulting from the local interactions of the individuals in the systems with their environment and with each other. The principles of swarm intelligence are derived from the behavioral trends
Chilled Beam System Market - Comparative Analysis 2025 | Trox GmbH (Germany), Fl …
Global Chilled Beam System Market – Overview In the recent times, the global market for chilled beam systems has been reporting a significant rise in its valuation. The rising demand for energy efficient buildings and the increasing need for enhanced occupant thermal comfort, indoor air quality, and floor-to-floor space saving is boosting the growth of this market considerably. However, the dearth of consumer awareness about these systems and high initial cost
Coding and Marking Market - Overview On Upcoming Need 2025 | Markem-Imaje, ID Te …
Global Coding and Marking Market: Overview The global market for coding and marking is projected to witness a steady growth in the next few years. As per the research study, the market is likely to register a 7% CAGR between 2017 and 2021. The rising demand for coding and packaging techniques from several industries, including cosmetic, food and beverage, pharmaceutical, and other industries. The rising competition among the key players has